Back to Results
First PageMeta Content
Pharmacology / Pharmacy / European Federation of Pharmaceutical Industries and Associations / Innovative Medicines Initiative / Etox / Pre-clinical development / Boehringer Ingelheim / Servier / Validation / Pharmaceutical sciences / Pharmaceutical industry / Science


eTox IMI Overview_0511 T Steger-Hartmann
Add to Reading List

Document Date: 2011-06-24 21:29:20

Open Document

File Size: 1,55 MB

Share Result on Facebook

Company

Bayer HealthCare Boehringer Ingelheim International GmbH / F. HOFFMANN-LA ROCHE AG / AstraZeneca AB / GlaxoSmithKline / H. Lundbeck A/S / Servier Sanofi-Aventis UCB Pharma SA / Participating EFPIA Partners Novartis Pharma AG / Janssen Pharmaceutica NV / Development LTD / Private Partnership / Pfizer Limited / /

Currency

EUR / /

IndustryTerm

chemical space / household chemicals / chemical features / pharmaceuticals / pharmaceutical industry / chemicals / /

Organization

European Federation of Pharmaceutical Industries and Associations / European Union / /

Person

Thomas Steger-Hartmann / Francois Pognan / /

Technology

Knowledge Management / Drug development / /

SocialTag